-
1 Comment
Medigard Limited is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Medigard Limited gets an overall score of 2/5.
| ISIN | AU000000MGZ2 |
|---|---|
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| CurrencyCode | AUD |
| Exchange | AU |
| Market Cap | 3M |
|---|---|
| PE Ratio | 10.0 |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | 0.39 |
Medigard Limited operates as a life sciences company in Australia. The company researches and develops medical technologies, including KT009 project to treat degenerative disk disease with an injectable product. Medigard Limited was founded in 1999 and is based in Main Beach, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MGZ.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
